Variable FZD7 expression in colorectal cancers indicates regulation by the tumour microenvironment
MetadataShow full item record
Recent evidence shows that a sub-population of Wnt/ß-catenin target genes is specifically induced in different tissue contexts. FZD7 is a putative Wnt/ß-catenin target gene and although it is highly expressed in well-differentiated colorectal cancer tumour cells, its expression is decreased in de-differentiated tumour cells at the invasive front despite elevated Wnt/ß-catenin signalling in this area. This variable expression of FZD7 implicates additional regulation by the microenvironment; however, this has not been investigated. To begin to elucidate the role of extracellular matrix in regulating FZD7 expression, we generated a FZD7 promoter reporter and analysed FZD7 promoter activity in colorectal cancer cells grown on different matrices. We demonstrate that the FZD7 promoter is regulated by ß-catenin in colorectal cancer cells and observed decreased promoter activity in cells grown on fibronectin but not collagen I or collagen IV. Thus, expression of FZD7 in colorectal cancer may be regulated by fibronectin in the microenvironment. © 2009 Wiley-Liss, Inc.
Showing items related by title, author, creator and subject.
Byun, D.; Ahmed, N.; Nasser, S.; Shin, J.; Al-Obaidi, S.; Goel, S.; Corner, G.; Wilson, A.; Flanagan, D.; Williams, D.; Augenlicht, L.; Vincan, Elizabeth; Mariadason, J. (2011)Intestinal epithelial-specific PTEN inactivation results in tumor formation. Am J Physiol Gastrointest Liver Physiol 301: G856-G864, 2011. First published August 11, 2011; doi:10.1152/ajpgi.00178.2011.-Phosphates and ...
The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progressionVincan, Elizabeth; Barker, N. (2008)The constitutive activation of ß-catenin-dependent ('canonical') Wnt signalling is a necessary initiating event in the genesis of most colorectal cancers. As this constitutive activation occurs through genetic mutation ...
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerMillen, R.; Malaterre, J.; Cross, R.; Carpinteri, S.; Desai, J.; Tran, B.; Darcy, P.; Gibbs, P.; Sieber, O.; Zeps, Nikolajs; Waring, P.; Fox, S.; Pereira, L.; Ramsay, R. (2016)The presence of tumor immune infiltrating cells (TILs), particularly CD8+ T-cells, is a robust predictor of outcome in patients with colorectal cancer (CRC). We revisited TIL abundance specifically in patients with ...